Abingworth raises $465m for new life sciences venture fund

Abingworth has closed its latest life sciences venture fund at $465 million, beating its $375 million.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this